Description
H-151 is a STING antagonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
H-151 is a STING antagonist.
| Cas No. | 941987-60-6 |
|---|---|
| Purity | ≥99% |
| Formula | C17H17N3O |
| Formula Wt. | 279.34 |
| Chemical Name | 1-(4-Ethylphenyl)-3-(1H-indol-3-yl) urea |
| IUPAC Name | 1-(4-ethylphenyl)-3-(1H-indol-3-yl)urea |
| Synonym | H151; N-(4-ethylphenyl)-N'-1H-indol-3-yl-urea |
| Appearance | Pale yellow to white solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zeng H, Gao Y, Yu W, et al. Pharmacological inhibition of STING/TBK1 signaling attenuates myeloid fibroblast activation and macrophage to myofibroblast transition in renal fibrosis. Front Pharmacol. 2022 Jul 18;13:940716. PMID: 35924048
Sun C, Wu G, Zhang Z, et al. Protein tyrosine phosphatase receptor type D regulates neuropathic pain after nerve injury via the STING-IFN-I pathway. Front Mol Neurosci. 2022 Apr 14;15:859166. PMID: 35493326
Hu S, Gao Y, Gao R, et al. The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction. Int Immunopharmacol. 2022 Jun;107:108658. PMID: 35278833
Chalcone; SIRT activator, GABA-A positive modul...
Steroid; AR antagonist.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
RIP1 inhibitor.
μOR and δOR agonist, D2/D3 DA potentiator.
Thiazolidine; Pim kinase inhibitor.
Cdc7 inhibitor.
Centrally acting muscle relaxant.
p110δ and p110γ PI3K inhibitor.
PAI-1 inhibitor.
α2-adrenergic and imidazoline-1 antagonist, AT...
Inhibitor of EGFR, HER2, and HER3.
5-HT3 antagonist.
Benzimidazole; microtubule polymerization inhib...
Alkaloid found in Catharanthus, precursor in sy...
STING agonist
Triterpenoid found in Vigna angularis and Trigo...
Quinolone, antioxidant.
Pheniramine derivative; histamine H1 and mAChR ...
pan-RAF inhibitor